We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$161M
AUM Growth
+$40.5M
Cap. Flow
+$31.6M
Cap. Flow %
19.6%
Top 10 Hldgs %
69.12%
Holding
94
New
46
Increased
25
Reduced
6
Closed
12

Top Buys

1
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.22M
2
COR icon
Cencora
COR
+$2.7M
3
COMS
COMSovereign Holding Corp. Common Stock
COMS
+$1.54M
4
AMZN icon
Amazon
AMZN
+$1.13M
5
SHW icon
Sherwin-Williams
SHW
+$1.09M

Top Sells

1
ALXN
Alexion Pharmaceuticals
ALXN
+$10.8M
2
JAMF
Jamf
JAMF
+$598K
3
CELU icon
Celularity
CELU
+$550K
4
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$297K
5
MELI icon
Mercado Libre
MELI
+$265K

Sector Composition

1 Financials 24.65%
2 Healthcare 19.41%
3 Communication Services 16.96%
4 Technology 8.47%
5 Industrials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.32T
$21.3M 13.2%
206,000
– –
ATH
2
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$16.8M 10.4%
333,000
– –
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$466B
$16M 9.89%
50,000
– –
MS icon
4
Morgan Stanley
MS
$343B
$15M 9.31%
193,562
+1,089
+0.6% +$83.5K
MS icon
5
CALL
Morgan Stanley
MS
$343B
$14.8M 9.14%
+190,000
New +$14.6M
CVS icon
6
CVS Health
CVS
$136B
$10M 6.21%
133,163
+825
+0.6% +$60.1K
VYNE icon
7
VYNE Therapeutics
VYNE
$25.6M
$7.11M 4.4%
57,675
– –
BMY icon
8
Bristol-Myers Squibb
BMY
$124B
$4.25M 2.63%
67,243
+6,588
+11% +$410K
CVS icon
9
CALL
CVS Health
CVS
$136B
$3.41M 2.11%
45,300
-15,700
-26% -$1.14M
COR icon
10
Cencora
COR
$59.9B
$2.95M 1.83%
+25,000
New +$2.7M
GBT
11
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.85M 1.77%
+70,000
New +$3.22M
GDX icon
12
CALL
VanEck Gold Miners ETF
GDX
$21.8B
$2.44M 1.51%
+75,000
New +$2.56M
SLV icon
13
CALL
iShares Silver Trust
SLV
$27.1B
$2.27M 1.41%
100,000
+50,000
+100% +$1.22M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.33T
$2.19M 1.36%
21,280
+8,260
+63% +$815K
EHTH icon
15
eHealth
EHTH
$47.3M
$2.18M 1.35%
30,000
+4,000
+15% +$256K
MSFT icon
16
Microsoft
MSFT
$2.98T
$2.17M 1.35%
9,218
+3,874
+72% +$899K
META icon
17
Meta Platforms (Facebook)
META
$1.69T
$1.78M 1.1%
6,050
+2,176
+56% +$586K
DVA icon
18
DaVita
DVA
$15B
$1.78M 1.1%
16,500
– –
AAPL icon
19
Apple
AAPL
$4.89T
$1.73M 1.07%
14,155
+8,463
+149% +$1.09M
AMZN icon
20
Amazon
AMZN
$2.69T
$1.46M 0.9%
9,420
+7,160
+317% +$1.13M
V icon
21
Visa
V
$694B
$1.28M 0.79%
6,059
+1,457
+32% +$307K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.23M 0.76%
4,805
+3,023
+170% +$734K
MA icon
23
Mastercard
MA
$487B
$1.21M 0.75%
3,403
+591
+21% +$206K
PYPL icon
24
PayPal
PYPL
$50B
$1.16M 0.72%
4,769
+429
+10% +$108K
COMS
25
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$1.09M 0.68%
+4,100
New +$1.54M
1
2 3 4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, DSC Advisors held 94 positions worth $161M, up 33% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

DSC Advisors deployed $31.6M of net new capital in Q1 2021, opening 46 new positions and adding to 25 existing holdings. Its largest new stake was Global Blood Therapeutics, Inc.: 70,000 shares worth $2.85M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Zoom, an estimated $71K trimmed.

  • DSC Advisors's largest Q1 2021 buy was Global Blood Therapeutics, Inc.: 70,000 shares worth $2.85M.
  • DSC Advisors added most to Amazon in Q1 2021, an estimated $1.13M increase.
  • DSC Advisors's biggest Q1 2021 reduction was Zoom, cutting an estimated $71K.
  • DSC Advisors fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $10.8M.
  • DSC Advisors's ten largest holdings make up 69% of its $161M portfolio in Q1 2021.
  • DSC Advisors opened 46 new positions and closed 12 in Q1 2021.
  • DSC Advisors's portfolio value rose 33% quarter-over-quarter to $161M.

Based on DSC Advisors's 13F filing for Q1 2021, filed 14 May 2021.